News | June 10, 2026
Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
Bengaluru-based startup will use the fresh capital to enter new markets, enhance technology capabilities, and scale its integrated care model
Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint
New Chesterbrook office strengthens customer engagement, partner collaboration, and regional expansion strategy
Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development
Deal expands SPI Pharma’s manufacturing footprint in Germany, enhances pharmaceutical ingredient offerings, and reinforces focus on fast-growing digestive health market
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
